A Randomized Controlled Trial of Fludrocortisone for the Treatment of Hyperkalemia in Hemodialysis Patients-Reference-Cited by-同舟云学术

A Randomized Controlled Trial of Fludrocortisone for the Treatment of Hyperkalemia in Hemodialysis Patients

Published:2006-05 Issue:5 Volume:47 Page:809-814
ISSN:0272-6386
Container-title:American Journal of Kidney Diseases
language:en
Short-container-title:American Journal of Kidney Diseases

Author:

Kaisar Mohammed O.,Wiggins Kathryn J.,Sturtevant Joanne M.,Hawley Carmel M.,Campbell Scott B.,Isbel Nicole M.,Mudge David W.,Bofinger Andrew,Petrie James J.B.,Johnson David W.

Publisher

Elsevier BV

Subject

Nephrology

Reference10 articles.

1. Temporal profile of serum potassium concentration in nondiabetic and diabetic outpatients on chronic dialysis;Tzamaloukas;Am J Nephrol,1987

2. Treating interdialytic hyperkalemia with fludrocortisone;Imbriano;Semin Dial,2003

3. Effect of various therapeutic approaches on plasma potassium and major regulating factors in terminal renal failure;Blumberg;Am J Med,1988

4. Mechanism and prevention of cardiac arrhythmias in chronic hemodialysis patients;Morrison;Kidney Int,1980

5. Safety and efficacy of low-potassium dialysate;Hou;Am J Kidney Dis,1989

Cited by 28 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Use of Fludrocortisone for Hyperkalemia in Chronic Kidney Disease Not Yet on Dialysis;Electrolytes & Blood Pressure;2024

2. Mechanisms and management of drug-induced hyperkalemia in kidney transplant patients;Reviews in Endocrine and Metabolic Disorders;2021-07-22

3. Management of hyperkalemia: A focus on kidney transplant recipients;Transplantation Reviews;2021-04

4. Current Management of Hyperkalemia in Patients on Dialysis;Kidney International Reports;2020-06

5. Potassium homeostasis and management of dyskalemia in kidney diseases: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference;Kidney International;2020-01